EBS:NYSE
Emergent Biosolutions Inc
7,16 USD
arrow_upward
+1,49%(+0,11) 1 D
12. okt., 13:52:12 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EBS …
Åpne
7,08 USD
Høy
7,33 USD
Lav
7,00 USD
Markedsverdi
367,12 mill.
Snittvolum
1,16 mill.
Volum
534,00k
52 u høy
14,06 USD
52 u lav
4,36 USD
EPS
−3,51 USD
Beta
2,28
Utestående aksjer
51,27 mill.
Antall ansatte
900
Åpne
7,08 USD
Høy
7,33 USD
Lav
7,00 USD
Markedsverdi
367,12 mill.
Snittvolum
1,16 mill.
Volum
534,00k
52 u høy
14,06 USD
52 u lav
4,36 USD
EPS
−3,51 USD
Beta
2,28
Utestående aksjer
51,27 mill.
Antall ansatte
900
Nyhetssaker
Fra nettkilder og nyhetspartnere
Invezz
·
for 2 døgn siden
Dow stiger 423 poeng etter teknologireprise, telekomaksjer faller på SpaceX
Invezz
·
for 5 timer siden
Topp 3 katalysatorer for S&P 500-indeksen denne uken: obligasjoner, kvartalstall, KPI
Vietnam.vn
·
for 16 timer siden
Hurtiglesning 12-10: Dow Jones stiger 423 poeng til tross for at avkastningen når en 24-årshøyde, Becamex og VSIP slår sammen to selskaper
Simply Wall Street
·
for 17 minutter siden
Why Does Space Exploration Technologies (SPCX) Need 15,000 More Satellites And Cape Launches?
Profil
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Om Emergent Biosolutions Inc
Administrerende direktørRobert G. Kramer Sr. | Joseph C. Papa
Ansatte900
Grunnlagt5. sep. 1998
HovedkontorRockville, Maryland, USA
Sektor-
Nettstedemergentbiosolutions.com